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The underlying data demonstrates that ﬁbroblast activation pro-
tein (FAP) paves the way for ﬁbrosarcoma cells, which require the
proteolysis of the extracellular matrix (ECM) and basement
membranes to intravasate from implanted subcutaneous primary
tumors into blood vessels, be transported to distant organs where
they extravasate from the blood vessels, reattach and proliferate to
metastases. The data additionally shows that FAP, when over-
expressed on ﬁbrosarcoma cells induces their invasion and for-
mation of spontaneous metastases in multiple organs, particularly
after subcutaneous co-implantation of the FAP-expressing and
wildtype ﬁbrosarcoma. The raw and processed data presented
herein is related to a research article entitled “Potential of activa-
table FAP-targeting immunoliposomes in intraoperative imaging of
spontaneous metastases” (F.L. Tansi, R. Rüger, C. Böhm, R.E. Kon-
termann, U.K. Teichgraeber, A. Fahr, I. Hilger, 2016) [1]. Further-
more, evidence for the detection of FAP-expressing tumor cells andvier Inc. This is an open access article under the CC BY license
/j.biomaterials.2016.02.028
F.L. Tansi).
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F.L. Tansi et al. / Data in Brief 9 (2016) 143–148144cells of the tumor stroma by activatable FAP-targeting liposomes is
presented in this dataset.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology, Chemistry
ore speciﬁc sub-
ject areaCancer biology and drug delivery systemsype of data Text ﬁle, table, ﬁgure
ow data was
acquiredHistology, Microscopyata format Raw and analyzed
xperimental
factorsMice implanted subcutaneously with wild type and FAP expressing ﬁbro-
sarcoma and used in Tansi et al. [1] were evaluated for metastases.xperimental
featuresHistological evaluation of spontaneous metastases in mice with FAP
expressing primary tumors.ata source
locationJena, Germanyata accessibility Data is available with this articleD
Value of the data
 Identifying and targeting the molecular factors that inﬂuence cancer metastases is useful for the
management of cancer.
 Overexpression of ﬁbroblast activation protein (FAP) by ﬁbrosarcoma cells inﬂuences their motility
and metastasis formation potential and is exploited in the design of models of spontaneous
metastases.
 Liposome-based ﬂuorescent agents are valuable tools for monitoring of spontaneous metastases
and image guided drug delivery and their preparation is valuable for research and drug discovery.1. Data
The data presented herein comprises tabulated observations and tumor volumes of mice co-
implanted with wildtype and FAP-expressing ﬁbrosarcoma cells, as well as histological sections of the
excised tumors and lungs. Also, a detailed data on the preparation of FAP-targeting immunoliposomes
is presented. Images of tumor sections demonstrating the localization of the liposomal ﬂuorescence
in FAP-expressing tumor cells and myoﬁbroblasts are also presented.2. Experimental design, materials and methods
2.1. Design and analysis of a model of FAP-induced spontaneous metastasis
The wild type human ﬁbrosarcoma cell line HT1080 and its stable FAP-expressing counterpart,
HT1080-FAP were co-implanted subcutaneously in immune deﬁcient nude mice [1] and the mice
observed and evaluated for the emergence of spontaneous metastases.
Table 1
Tumor volumes of subcutaneous HT1080 and HT1080-FAP tumors 6 weeks or 8 weeks (grey shadow) post implantation
and respective observations made with respect to metastases.
hp: hyperplasia, met: metastatic lesion.
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The tumors were measured with a caliper and the tumor volumes were derived according to the
literature [2]. The wildtype HT1080 cells produced xenografts with normal growth in 75% (15 of 20)
and small tumors in 25% (5 of 20) of the animals, whereas the transfected HT1080-FAP cells revealed
no or only very small xenografts in all the animals investigated (Table 1).2.1.2. Histological analysis and microscopic detection of spontaneous lung metastases and inﬁltrating
cells originating from subcutaneous primary tumors
Histological slices of HT1080-hFAP and HT1080-wt tumors and lungs excised from mice models
bearing single or double-implants were stained with hematoxylin and Eosin and subjected to
microscopy. HT1080-hFAP tumors from mice with double implants revealed very few clusters of cells
and areas of single cells migrating through the matrigel used for implantation, whereas slices of the
HT1080-wt derived tumors revealed normal growth and distribution of the cells (Fig. 1, Tumors).
Furthermore, histological analysis of the lungs from the animals bearing both tumors revealed a high
level of lung metastasis and hyperplasia resulting from inﬁltrating tumor cells (Fig. 1A, Lungs).
Opposed to this, mice implanted with the FAP expressing HT1080-hFAP tumors alone showed slow
but relatively improved tumor growth (Fig. 1B, Tumors) and a high level of lung hyperplasia of
inﬁltrating tumor cells, but no visible large lung metastases (Fig. 1B, Lungs). On the other hand, mice
implanted with the wildtype HT1080 alone revealed rapid tumor growth, and the respective lung
slices showed no signiﬁcant abnormalities (Fig. 1C).
Fig. 1. FAP induced motility of tumor cells and formation of spontaneous metastases in mice models. (A) Representative mouse
implanted with both HT1080-hFAP and HT1080-wt, (B) with HT1080-hFAP alone and (C) with HT1080-wt alone and histolo-
gical slices of the respective tumors and lungs excised 6–8 weeks post implantation. Histological stain of tumor and lung slices
was with hematoxylin (nuclei) and eosin (cytoplasm). Whole mount microscopic images of the lung slice was done with the
Keyence-BZ9000 microscope at a 4x magniﬁcation and the images fused. The detailed images were done at 60x magniﬁcation
with an Olympus BX50 microscope. Yellow arrows point at inﬁltrating tumor cells in the lungs. Scale bars: 50 mm.
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2.2.1. Materials
The egg phosphatidylcholine (EPC) was purchased from Lipoid (Ludwigshafen, Germany), whereas
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol)2000] (ammo-
nium salt) (mPEG2000-DSPE), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(poly-
ethylene glycol)2000] (ammonium salt) (Mal-PEG2000-DSPE) and 1,2-dioleoyl-sn-glycero-3-phos-
phoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD-DOPE) were from
Avanti Polar Lipids (Alabaster, USA). Cholesterol, Tris(hydroxymethyl)-aminomethane (Tris) and
4-(1,1,3,3-Tetramethylbutyl)phenyl-polyethylene glycol (Triton-X100) were from Sigma (Taufkirchen,
Germany). The near infrared ﬂuorescent dye, DY-676-COOH was purchased from DYOMICS GmbH (Jena,
Germany).
The recombinant FAP speciﬁc single chain antibody fragment (FAP-scFv) containing a c-terminal
cysteine residue was puriﬁed from transformed Escherichia coli as reported earlier [3].
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The liposomes were prepared by the standard ﬁlm hydration and extrusion method composed of
the lipid combination EPC:Chol:mPEG2000-DSPE at a molar ratio of 6.5:3:0.5 as reported in detail
elsewhere [4]. The resulting DY-676-COOH containing liposomes were dispersed in buffer (10 mM
Tris, pH 7.4) to have a ﬁnal lipid concentration of 50 mM.2.2.3. Conjugation of FAP'scFv fragments to get FAP-targeting immunoliposomes
FAP-Immunoliposomes (FAP-IL) were obtained by post-insertion of scFv’FAP-Mal-PEG2000-DSPE
micelles to preformed quenched liposomes as described earlier [5]. For this purpose, the
Mal-PEG2000-DSPE micelles were prepared and conjugated to reduced ligands (scFv’FAP) according to
Mack et al. [6]. The resulting immunoliposomes were also dispersed in buffer (10 mM Tris, pH 7.4) to
have a ﬁnal lipid concentration of 50 mM.2.2.4. Quantitation of liposomal encapsulated DY-676-COOH
To determine the amount of DY-676-COOH encapsulated, a calibration curve was prepared with
different concentrations of the free DY-676-COOH (0, 82, 124, 247, 494, 741, 988 nM) in 10 mM Tris
buffer, pH 7.4 containing 0.1% Triton X100. The liposome samples were incubated for 5 min at RT in
buffer containing 1% Triton X100 and afterwards diluted with 10 mM Tris buffer, pH 7.4 to a ﬁnal
Triton-X100 concentration of 0.1%. All samples were measured in triplicates on a Fluostar Optima
microplate reader (BMG Labtech, GmbH, Ortenberg, Germany) at λ¼700 nm after excitation at
λ¼645 nm.Fig. 2. Microscopic detection of FAP-IL based ﬂuorescence in tumor slices. Histological slices of FAP-expressing (HT1080-hFAP)
and wild type FAP-negative (HT1080-wt) tumor models reveal characteristic FAP-IL ﬂuorescence in tumor cells (white arrow)
and tumor stromal cells (yellow arrows) 24 h post intravenous injection. No Fluorescence is seen after injection of buffer (PBS).
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Subcutaneous tumors were excised from mice 24 h post intravenous injection of FAP-IL (30 mmol/
kg body weight) or PBS. Slices of the parafﬁn embedded tumors were prepared, dewaxed as described
in [1] and subjected to confocal laser scanning microscopy. The data demonstrates FAP-IL-based
ﬂuorescence in tumor cells and stroma of the FAP-expressing tumor model and only in the stroma of
the wild type tumor model (Fig. 2, FAP-IL). No ﬂuorescence is seen in tumors from control mice which
were injected with PBS (Fig. 2, PBS).Acknowledgments
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